Intelgenx Technologs (IGX)

0.29
+0.03(+9.26%)
  • Volume:
    8,692
  • Bid/Ask:
    0.29/0.31
  • Day's Range:
    0.29 - 0.29

IGX Overview

Prev. Close
0.27
Day's Range
0.29-0.29
Revenue
943.82K
Open
0.29
52 wk Range
0.15-0.49
EPS
-0.068
Volume
8,692
Market Cap
52.92M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
25,184
P/E Ratio
-2.65
Beta
2.47
1-Year Change
-25%
Shares Outstanding
174,646,197
Next Earnings Date
Mar 22, 2023
What is your sentiment on Intelgenx Technologs?
or
Market is currently closed. Voting is open during market hours.

Intelgenx Technologs News

Intelgenx Technologs Analysis

Intelgenx Technologs Company Profile

Intelgenx Technologs Company Profile

Employees
50
  • Type:Equity
  • Market:Canada
  • ISIN:US45822R1014
  • CUSIP:45822R101

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellSellBuySell
Technical IndicatorsStrong SellStrong SellStrong SellBuyStrong Sell
SummaryStrong SellStrong SellStrong SellBuyStrong Sell